|Bid||21.80 x N/A|
|Ask||22.60 x N/A|
|Day's Range||21.80 - 21.80|
|52 Week Range||12.00 - 26.80|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 08, 2023 - May 12, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
COLL vs. ZTS: Which Stock Is the Better Value Option?
Pacira BioSciences (PCRX) reports mixed fourth-quarter financial results, where earnings match estimates, but revenues miss the mark.
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q4 2022 Earnings Call Transcript February 23, 2023 Operator: Greetings, and welcome to the Collegium Pharmaceutical Fourth Quarter and Full Year 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. Please note, that this conference call is being […]